What is the market price of a bottle of 0.01% atropine sulfate eye drops (EIKANCE)?

0.01% Atropine Sulfate Eye Drops (EIKANCE) is a drug mainly used to control the progression of myopia in children. Its most significant benefit is that it can slow down the growth of the axial length of the eye, thereby effectively controlling the progression of myopia. This drug is widely used to prevent and control myopia in children aged 4-14, and is especially suitable for teenagers whose myopia progresses rapidly.

During the use of 0.01% Atropine Sulfate Eye Drops, atropine slows down the growth of the eyeball by acting on the ciliary muscle of the eye. Compared with high-concentration atropine, low-concentration 0.01% atropine sulfate can reduce side effects caused by the drug, such as pupil dilation, light sensitivity, and blurred near vision. Because of its small side effects, it is suitable for long-term use, especially in the prevention and control of myopia in children, making it a safe and effective treatment option.

As for the market pricing of 0.01% Atropine Sulfate Eye Drops, the original drug has not yet been launched in the Chinese market, and it is not included in medical insurance, so the price information is relatively uncertain. However, the drug has been launched in overseas markets. The common specification is 30 pieces of 0.01% 0.3ml. Each box is sold for about 600 RMB. The price may fluctuate due to exchange rate changes. In other countries, especially Europe, the United States and parts of Asia, the price of atropine eye drops is generally in a similar range, and the specific price varies according to the region, drug suppliers and market conditions.

In addition, with the increase in market demand, more and more generic drugs have entered the market. Some of them, such as 0.01% Atropine Sulfate Eye Drops produced in India, may be more affordable, with the price of each drug being about tens of RMB. Although generic drugs contain similar ingredients to brand-name drugs, they may differ in quality and stability. Therefore, patients and parents should be cautious when choosing to purchase and give priority to reputable brands and suppliers.

Reference: https://www.eikance.com.au/